VRTX — VERTEX PHARMACEUTICALS INC

Ownership history in MCRAE CAPITAL MANAGEMENT INC  ·  16 quarters on record

This page tracks every 13F SEC filing in which MCRAE CAPITAL MANAGEMENT INC reported a position in VERTEX PHARMACEUTICALS INC (VRTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.63% (2023 Q3)
Avg. % of fund
3.03%
First filed
2022 Q1
Last filed
2025 Q4
Quarters held
16
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 35,558 +2,399 +7.2% 3.29% $16.1M $453.36
2025 Q3 ADDED 33,159 +2,706 +8.9% 2.58% $13.0M $391.64
2025 Q2 ADDED 30,453 +125 +0.4% 2.78% $13.6M $445.20
2025 Q1 REDUCED 30,328 -750 -2.4% 3.10% $14.7M $484.82
12 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    VRTX price (monthly, adj. close)

Other funds also holding VRTX

As of 2025 Q4 — sorted by position size

Provident Investment Management, Inc. 3Y 7Y 6.16% Bellevue Group AG 3Y 7Y 5.85% Andrew Hill Investment Advisors, Inc. 3Y 4.28% Iron Triangle Partners LP 3Y 3.99% Atle Fund Management AB 3Y 7Y 3.32% Sofinnova Investments, Inc. 3Y 7Y 3.22% SECTORAL ASSET MANAGEMENT INC 3Y 7Y 2.91% Birch Hill Investment Advisors LLC 3Y 7Y 2.89% NIA IMPACT ADVISORS, LLC 3Y 2.68% AIMZ Investment Advisors, LLC 3Y 7Y 2.63%
← Back to MCRAE CAPITAL MANAGEMENT INC Holdings